Corp Cytrx serves as Executive at RXI PHARMACEUTICALS CORP, where they oversee executive responsibilities. Since joining the company, Corp Cytrx has executed 7 insider transactions totaling $17.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 29, 2010 involved selling 2,593,881 shares valued at $5.7M.
Corp Cytrx currently holds 2,593,881 shares of RXI PHARMACEUTICALS CORP (RXII), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Corp Cytrx has been a net seller of RXII stock. They have purchased $0 and sold $17.2M worth of shares.
Corp Cytrx's most recent insider trade was on Dec 29, 2010, when they sold 2,593,881 shares at $2.20 per share.
Get notified when new Form 4 filings are submitted
| $2.65 |
| Discretionary |
| Jun 30, 2010 | RXII | $5.1M | Sale | 2,000,000 | $2.55 | Discretionary |
| Mar 26, 2010 | RXII | $3.8M | Sale | 675,000 | $5.70 | Discretionary |
| Sep 23, 2009 | RXII | $1.3M | Sale | 500,000 | $2.50 | Discretionary |
| Mar 11, 2008 | RXII | $0 | Other | 4,526,624 | $N/A | Discretionary |
| Mar 11, 2008 | RXII | $0 | Other | 27,694 | $N/A | Discretionary |